MTOR and osteosarcoma: HSP90AA1 inhibited osteosarcoma cell apoptosis by deactivating the JNK/P38 pathway and promoted autophagic protection in response to chemotherapy by blocking the PI3K/AKT/mTOR signaling pathway, thus serving as an important regulator of osteosarcoma survival 26.